Tag: Europe
-
Internet-of-Things Security Architecture Designed
19 June 2015. Engineering students at Ruhr-Universität Bochum in Germany are developing a security architecture to protect wireless communications among small household devices connected in what’s known as the Internet-of-Things. The team from the university’s Horst Görtz Institute that specializes in IT security is also receiving funds from a German government program to start a…
-
Anti-Infection Compound Devised for Dental, Wound Care
18 June 2015. A new formulation of a common antibacterial agent can protect against infections for weeks or months at a time, according to its developers at University of Bristol in the U.K. The team led by Bristol dental materials scientist Michele Barbour is developing Pertinax, an extended antimicrobial compound, and receiving this year’s £25,000…
-
Companies Form Fertility Treatment Technologies Alliance
8 June 2015. An alliance of drug, genomic, and assisted fertility technology companies are collaborating on processes and standards that encourage more consistency in results from assisted reproductive treatment labs. Financial details of the Global Fertility Alliance joining Illumina, Merck, and Genea were not disclosed. The three companies aim to improve outcomes in fertility clinics…
-
Antibiotic Developer Adds $9.2 Million in Early Funds
3 June 2015. Auspherix Limited, a start-up developer of new antibiotic drugs, raised £6 million ($US 9.2 million) in early-stage venture financing. Funding for the two year-old enterprise, located in a pharmaceutical and biotechnology incubator at Stevenage, U.K., was led by technology commercialization company Imperial Innovations plc, with earlier investor Australia’s Medical Research Commercialisation Fund.…
-
Spin-Off Biotech Formed for Autoimmune Disorders
2 June 2015. Drug maker Astellas Pharma Inc. in Tokyo and Anokion SA, a biotechnology company in Lausanne, Switzerland, are forming Kanyos Bio Inc., a spin-off enterprise to develop therapy candidates for autoimmune diseases. The deal could bring Kanyos Bio, based in Cambridge, Massachusetts, as much as $760 million, as well as an equity investment…
-
Mini Gamma Camera Developed, Spin-Off Company Formed
1 June 2015. Physicists and medical researchers at two universities in the U.K. designed a hand-held camera that performs gamma ray imaging, normally requiring a powerful room-sized device for diagnosing tumors and other medical functions. The team from Universities of Leicester and Nottingham also formed a spin-off company, Gamma Technologies Ltd., to take the device…
-
Health Data, Analytics Firms to Boost Cancer Trial Access
29 May 2015. A health data company and genetic analytics firm are beginning a service that they say will make it easier for cancer patients to take part in clinical trials of new drugs. Financial details of the collaboration between Guardian Research Network in Spartanburg, South Carolina and Molecular Health in Cambridge, Massachusetts were not…
-
Smartphone Vision App Found Accurate as Clinic Test
29 May 2015. An inexpensive smartphone-based test was found to measure visual acuity as well as the familiar standard eye chart used in clinics. The team that developed the Portable Eye Examination Kit or Peek at the London School of Hygiene and Tropical Medicine and other institutions in the U.K. published its results in yesterday’s…
-
AstraZeneca Building New Biologics Plant
18 May 2015. The pharmaceutical company AstraZeneca plans to build a new facility in Södertälje, Sweden to manufacture biologic medications. The $285 million plant is expected to employ from 150 to 250 workers when it goes into operation in 2019. Södertälje is the site of AstraZeneca’s largest factory for making tablets and capsules, as well…
-
Trial Shows Antibody Reduces Days with Migraines
15 May 2015. A clinical trial shows high doses of an engineered antibody reduced the number of days per month that people with a history of migraines experience migraine episodes. First findings from the intermediate-stage trial of the antibody code-named AMG334 by the biotechnology company Amgen were reported at a meeting of the International Headache…